The programme of the 2023 EFMC International Symposium on Chemical Biology will include the following sessions:

• Chemical Immunology & Checkpoint Inhibitors
  Chair: Sascha Hoogendoorn, University of Geneva, Switzerland 

• Chemical Proteomics in Drug Discovery
  Chair: Sebastian Essig, Bayer, Germany

• Chemically Induced Proximity
  Chair: Gonçalo Bernardes, University of Cambridge, United Kingdom 

• Computational Chemical Biology (LS-EuChemS Session)
  Chair: Sonsoles Martin Santamaria, CIB-CSIC, Spain 

• New Understanding of Post-translational Modifications
  Chair: Christian Adam Olsen, University of Copenhagen, Denmark

• Protein Conformations: Beyond the Ground State
  Chair: Wolfgang Jahnke, Novartis, Switzerland

• Target Engagement and Mechanism of Action Determination
  Chair: Andrew Zhang, AstraZeneca, United States 

• Targeting Metabolism (ICBS Session)
  Chair: Zaneta Nikolovska-Coleska, University of Michigan, United States